Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help

OncoImmunology

Volumn 5, Issue 9, 2016, Pages

  Ni, Jing ^a   Hölsken, Oliver ^a   Miller, Matthias ^a   Hammer, Quirin ^b   Luetke Eversloh, Merlin ^b   Romagnani, Chiara ^b   Cerwenka, Adelheid ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Adoptive transfer; CD4+ help; IFN ; natural killer cells; tumor immunology

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; LUCIFERIN;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENETIC TRANSCRIPTION; HUMAN; IFNG GENE; MOUSE; NATURAL KILLER CELL; NONHUMAN; T CELL DEPLETION;

EID: 84988409805     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1219009     Document Type: Article

References (52)

1. M.Terme, E.Ullrich, N.F.Delahaye, N.Chaput, L.Zitvogel. Natural killer cell-directed therapies:moving from unexpected results to successful strategies. Nat Immunol 2008; 9:486-94; PMID:18425105; http://dx.doi.org/10.1038/ni1580
2. A.Velardi. Natural killer cell alloreactivity 10 years later. Curr Opin Hematol 2012; 19:421-6; PMID:22954728; http://dx.doi.org/10.1097/MOH.0b013e3283590395
3. D.A.Knorr, V.Bachanova, M.R.Verneris, J.S.Miller. Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol 2014; 26:161-72; PMID:24618042; http://dx.doi.org/10.1016/j.smim.2014.02.002
4. J.S.Miller, Y.Soignier, A.Panoskaltsis-Mortari, S.A.McNearney, G.H.Yun, S.K.Fautsch, D.McKenna, C.Le, T.E.Defor, L.J.Burns et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005; 105:3051-7; PMID:15632206; http://dx.doi.org/10.1182/blood-2004-07-2974
5. A.Curti, L.Ruggeri, A.D'Addio, A.Bontadini, E.Dan, M.R.Motta, S.Trabanelli, V.Giudice, E.Urbani, G.Martinelli et al. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. Blood 2011; 118:3273-9; PMID:21791425; http://dx.doi.org/10.1182/blood-2011-01-329508
6. N.Schmitz, H.S.Wu, B.Glass. Allogeneic transplantation in T-cell lymphomas. Semin Hematol 2014; 51:67-72; PMID:24468318; http://dx.doi.org/10.1053/j.seminhematol.2013.11.010
7. M.R.Parkhurst, J.P.Riley, M.E.Dudley, S.A.Rosenberg. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 2011; 17:6287-97; PMID:21844012; http://dx.doi.org/10.1158/1078-0432.CCR-11-1347
8. M.A.Cooper, J.M.Elliott, P.A.Keyel, L.Yang, J.A.Carrero, W.M.Yokoyama. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci USA 2009; 106:1915-9; PMID:19181844; http://dx.doi.org/10.1073/pnas.0813192106
9. J.Ni, M.Miller, A.Stojanovic, N.Garbi, A.Cerwenka. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 2012; 209:2351-65; PMID:23209317; http://dx.doi.org/10.1084/jem.20120944
10. M.P.Keppel, L.Yang, M.A.Cooper. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. J Immunol 2013; 190:4754-62; PMID:23530145; http://dx.doi.org/10.4049/jimmunol.1201742
11. R.Romee, S.E.Schneider, J.W.Leong, J.M.Chase, C.R.Keppel, R.P.Sullivan, M.A.Cooper, T.A.Fehniger. Cytokine activation induces human memory-like NK cells. Blood 2012; 10:4751-60; PMID:22983442; http://dx.doi.org/10.1182/blood-2012-04-419283
12. J.W.Leong, J.M.Chase, R.Romee, S.E.Schneider, R.P.Sullivan, M.A.Cooper, T.A.Fehniger. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol Blood Marrow Transplant 2014; 20:463-73; PMID:24434782; http://dx.doi.org/10.1016/j.bbmt.2014.01.006
13. A.Cerwenka, L.L.Lanier. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol 2016; 16:112-23; PMID:26806484; http://dx.doi.org/10.1038/nri.2015.9
14. A.Balasubramani, R.Mukasa, R.D.Hatton, C.T.Weaver. Regulation of the Ifng locus in the context of T-lineage specification and plasticity. Immunol Rev 2010; 238:216-32; PMID:20969595; http://dx.doi.org/10.1111/j.1600-065X.2010.00961.x
15. D.U.Lee, O.Avni, L.Chen, A.Rao. A distal enhancer in the interferon-gamma (IFN-gamma) locus revealed by genome sequence comparison. J Biol Chem 2004; 279:4802-10; PMID:14607827; http://dx.doi.org/10.1074/jbc.M307904200
16. M.Shnyreva, W.M.Weaver, M.Blanchette, S.L.Taylor, M.Tompa, D.R.Fitzpatrick, C.B.Wilson. Evolutionarily conserved sequence elements that positively regulate IFN-gamma expression in T cells. Proc Natl Acad Sci USA 2004; 101:12622-7; PMID:15304658; http://dx.doi.org/10.1073/pnas.0400849101
17. B.Jones, J.Chen. Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J 2006; 25:2443-52; PMID:16724115; http://dx.doi.org/10.1038/sj.emboj.7601148
18. J.R.Schoenborn, M.O.Dorschner, M.Sekimata, D.M.Santer, M.Shnyreva, D.R.Fitzpatrick, J.A.Stamatoyannopoulos, C.B.Wilson. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol 2007; 8:732-42; PMID:17546033; http://dx.doi.org/10.1038/ni1474
19. C.M.Tato, G.A.Martins, F.A.High, C.B.DiCioccio, S.L.Reiner, C.A.Hunter. Cutting edge:innate production of IFN-gamma by NK cells is independent of epigenetic modification of the IFN-gamma promoter. J Immunol 2004; 173:1514-7; http://dx.doi.org/10.4049/jimmunol.173.3.1514
20. M.Luetke-Eversloh, Q.Hammer, P.Durek, K.Nordstrom, G.Gasparoni, M.Pink, A.Hamann, J.Walter, H.D.Chang, J.Dong et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog 2014; 10:e1004441; PMID:25329659; http://dx.doi.org/10.1371/journal.ppat.1004441
21. M.A.Williams, B.J.Holmes, J.C.Sun, M.J.Bevan. Developing and maintaining protective CD8+ memory T cells. Immunol Rev 2006; 211:146-53; PMID:16824124; http://dx.doi.org/10.1111/j.0105-2896.2006.00389.x
22. X.S.He, M.Draghi, K.Mahmood, T.H.Holmes, G.W.Kemble, C.L.Dekker, A.M.Arvin, P.Parham, H.B.Greenberg. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest 2004; 114:1812-9; PMID:15599406; http://dx.doi.org/10.1172/JCI22797
23. Z.Li, F.Pradera, T.Kammertoens, B.Li, S.Liu, Z.Qin. Cross-talk between T cells and innate immune cells is crucial for IFN-gamma-dependent tumor rejection. J Immunol 2007; 179:1568-76; PMID:17641023; http://dx.doi.org/10.4049/jimmunol.179.3.1568
24. A.Horowitz, K.C.Newman, J.H.Evans, D.S.Korbel, D.M.Davis, E.M.Riley. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol 2010; 184:6043-52; PMID:20427769; http://dx.doi.org/10.4049/jimmunol.1000106
25. A.Horowitz, R.H.Behrens, L.Okell, A.R.Fooks, E.M.Riley. NK cells as effectors of acquired immune responses:effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol 2010; 185:2808-18; PMID:20679529; http://dx.doi.org/10.4049/jimmunol.1000844
26. F.Bihl, J.Pecheur, B.Breart, G.Poupon, J.Cazareth, V.Julia, N.Glaichenhaus, V.M.Braud. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol 2010; 185:2174-81; PMID:20624944; http://dx.doi.org/10.4049/jimmunol.1001486
27. K.Shimizu, M.Asakura, S.Fujii. Prolonged antitumor NK cell reactivity elicited by CXCL10-expressing dendritic cells licensed by CD40L+ CD4+ memory T cells. J Immunol 2011; 186:5927-37; PMID:21460206; http://dx.doi.org/10.4049/jimmunol.1003351
28. M.N.Kelly, M.Zheng, S.Ruan, J.Kolls, A.D'Souza, J.E.Shellito. Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J Immunol 2013; 190:285-95; PMID:23203926; http://dx.doi.org/10.4049/jimmunol.1200861
29. G.Gasteiger, S.Hemmers, P.D.Bos, J.C.Sun, A.Y.Rudensky. IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med 2013; 210:1179-87; PMID:23650439; http://dx.doi.org/10.1084/jem.20122571
30. G.Gasteiger, S.Hemmers, M.A.Firth, A.Le Floc'h, M.Huse, J.C.Sun, A.Y.Rudensky. IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med 2013; 210:1167-78; PMID:23650441; http://dx.doi.org/10.1084/jem.20122462
31. J.Sitrin, A.Ring, K.C.Garcia, C.Benoist, D.Mathis. Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med 2013; 210:1153-65; PMID:23650440; http://dx.doi.org/10.1084/jem.20122248
32. S.E.Street, J.A.Trapani, D.MacGregor, M.J.Smyth. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 2002; 196:129-34; PMID:12093877; http://dx.doi.org/10.1084/jem.20020063
33. G.P.Dunn, C.M.Koebel, R.D.Schreiber. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6:836-48; PMID:17063185; http://dx.doi.org/10.1038/nri1961
34. S.J.Szabo, B.M.Sullivan, C.Stemmann, A.R.Satoskar, B.P.Sleckman, L.H.Glimcher. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002; 295:338-42; PMID:11786644; http://dx.doi.org/10.1126/science.1065543
35. B.Min, H.Yamane, J.Hu-Li, W.E.Paul. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J Immunol 2005; 174:6039-44; PMID:15879097; http://dx.doi.org/10.4049/jimmunol.174.10.6039
36. T.Onoe, H.Kalscheuer, M.Chittenden, G.Zhao, Y.G.Yang, M.Sykes. Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs. J Immunol 2010; 184:6756-65; PMID:20483739; http://dx.doi.org/10.4049/jimmunol.0901711
37. H.Gudmundsdottir, L.A.Turka. A closer look at homeostatic proliferation of CD4+ T cells:costimulatory requirements and role in memory formation. J Immunol 2001; 167:3699-707; PMID:11564785; http://dx.doi.org/10.4049/jimmunol.167.7.3699
38. J.S.Orange, C.A.Biron. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 1996; 156:4746-56; PMID:8648121
39. D.M.Andrews, A.A.Scalzo, W.M.Yokoyama, M.J.Smyth, M.A.Degli-Esposti. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003; 4:175-81; PMID:12496964; http://dx.doi.org/10.1038/ni880
40. J.Dong, H.D.Chang, C.Ivascu, Y.Qian, S.Rezai, A.Okhrimenko, L.Cosmi, L.Maggi, F.Eckhardt, P.Wu et al. Loss of methylation at the IFNG promoter and CNS-1 is associated with the development of functional IFN-gamma memory in human CD4(+) T lymphocytes. European J Immunol 2013; 43:793-804; PMID:23255246; http://dx.doi.org/10.1002/eji.201242858
41. Q.Yu, V.T.Thieu, M.H.Kaplan. Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Ralpha gene during Th1 differentiation. EMBO J 2007; 26:2052-60; PMID:17380127; http://dx.doi.org/10.1038/sj.emboj.7601653
42. M.Shi, T.H.Lin, K.C.Appell, L.J.Berg. Janus-kinase-3-dependent signals induce chromatin remodeling at the Ifng locus during T helper 1 cell differentiation. Immunity 2008; 28:763-73; PMID:18549798; http://dx.doi.org/10.1016/j.immuni.2008.04.016
43. D.R.Fitzpatrick, K.M.Shirley, L.E.McDonald, H.Bielefeldt-Ohmann, G.F.Kay, A.Kelso. Distinct methylation of the interferon gamma (IFN-gamma) and interleukin 3 (IL-3) genes in newly activated primary CD8+ T lymphocytes:regional IFN-gamma promoter demethylation and mRNA expression are heritable in CD44(high)CD8+ T cells. J Exp Med 1998; 188:103-17; PMID:9653088; http://dx.doi.org/10.1084/jem.188.1.103
44. J.Lee, T.Zhang, I.Hwang, A.Kim, L.Nitschke, M.Kim, J.M.Scott, Y.Kamimura, L.L.Lanier, S.Kim. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 2015; 42:431-42; PMID:25786175; http://dx.doi.org/10.1016/j.immuni.2015.02.013
45. H.Schlums, F.Cichocki, B.Tesi, J.Theorell, V.Beziat, T.D.Holmes, H.Han, S.C.Chiang, B.Foley, K.Mattsson et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015; 42:443-56; PMID:25786176; http://dx.doi.org/10.1016/j.immuni.2015.02.008
46. J.H.Bream, D.L.Hodge, R.Gonsky, R.Spolski, W.J.Leonard, S.Krebs, S.Targan, A.Morinobu, J.J.O'Shea, H.A.Young. A distal region in the interferon-gamma gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2. J Biol Chem 2004; 279:41249-57; PMID:15271977; http://dx.doi.org/10.1074/jbc.M401168200
47. J.Yu, M.Wei, B.Becknell, R.Trotta, S.Liu, Z.Boyd, M.S.Jaung, B.W.Blaser, J.Sun, D.M.BensonJr et al. Pro- and antiinflammatory cytokine signaling:reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006; 24:575-90; PMID:16713975; http://dx.doi.org/10.1016/j.immuni.2006.03.016
48. V.Bachanova, L.J.Burns, D.H.McKenna, J.Curtsinger, A.Panoskaltsis-Mortari, B.R.Lindgren, S.Cooley, D.Weisdorf, J.S.Miller. Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother 2010; 59:1739-44; PMID:20680271; http://dx.doi.org/10.1007/s00262-010-0896-z
49. K.Hochweller, J.Striegler, G.J.Hammerling, N.Garbi. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. European J Immunol 2008; 38:2776-83; PMID:18825750; http://dx.doi.org/10.1002/eji.200838659
50. C.Sunderkotter, T.Nikolic, M.J.Dillon, N.Van Rooijen, M.Stehling, D.A.Drevets, P.J.Leenen. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172:4410-7; http://dx.doi.org/10.4049/jimmunol.172.7.4410
51. A.Cerwenka, J.L.Baron, L.L.Lanier. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001; 98:11521-6; PMID:11562472; http://dx.doi.org/10.1073/pnas.201238598
52. A.Cerwenka, A.B.Bakker, T.McClanahan, J.Wagner, J.Wu, J.H.Phillips, L.L.Lanier. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12:721-7; PMID:10894171; http://dx.doi.org/10.1016/S1074-7613(00)80222-8